Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G R Yang
Activity of the Multikinase Inhibitor Dasatinib Against Ovarian Cancer Cells
British Journal of Cancer
Cancer Research
Oncology
Related publications
Auranofin Displays Anticancer Activity Against Ovarian Cancer Cells Through FOXO3 Activation Independent of P53
International Journal of Oncology
Cancer Research
Oncology
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin Against Drug-Resistant Ovarian Cancer Cells
Angewandte Chemie
Redirecting Mouse T Hybridoma Against Human Breast and Ovarian Carcinomas: In Vivo Activity Against HER-2/neu Expressing Cancer Cells
British Journal of Cancer
Cancer Research
Oncology
Proapoptotic Activity of Achillea Membranacea Essential Oil and Its Major Constituent 1,8-Cineole Against A2780 Ovarian Cancer Cells
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, Against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation
Clinical Cancer Research
Cancer Research
Oncology
Synergistic Cytotoxic Effect of Sulindac and Pyrrolidine Dithiocarbamate Against Ovarian Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
PLoS ONE
Multidisciplinary